DNA binding-independent transcriptional activation of the vascular endothelial growth factor gene (VEGF) by the Myb oncoprotein

Biochemical and Biophysical Research Communications

Volumn 344, Issue 4, 2006, Pages 1300-1307

  Lutwyche, Jodi K ^a   Keough, Rebecca A ^a   Hunter, Julie ^a   Coles, Leeanne S ^a   Gonda, Thomas J ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Angiogenesis; Autocrine; DNA binding; Myb; Transactivation; VEGF promoter

Indexed keywords

ONCOPROTEIN; PROTEIN MYB; TRANSCRIPTION FACTOR SP1; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; BAY REGION BINDING SITE; BONE MARROW CELL; CANCER GENETICS; CARCINOGENESIS; CONTROLLED STUDY; DNA BINDING MOTIF; DNA MICROARRAY; FUNCTIONAL PROTEOMICS; GENE ACTIVITY; GENE IDENTIFICATION; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; MUTAGENESIS; MUTANT; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REPORTER GENE; SIGNAL TRANSDUCTION; SOLID TUMOR; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; WILD TYPE;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; DNA; MICE; MOLECULAR SEQUENCE DATA; MUTATION; MYELOID CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MYB; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; MURINAE;

EID: 33646188094     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.04.045     Document Type: Article

References (47)

1. Ganter B., and Lipsick J.S. Myb and oncogenesis. Adv. Cancer Res. 76 (1999) 21-60
2. Oh I.H., and Reddy E.P. The myb gene family in cell growth, differentiation and apoptosis. Oncogene 18 (1999) 3017-3033
3. Biroccio A., Benassi B., D'Agnano I., D'Angelo C., Buglioni S., Mottolese M., Ricciotti A., Citro G., Cosimelli M., Ramsay R.G., Calabretta B., and Zupi G. c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings. Am. J. Pathol. 158 (2001) 1289-1299
4. Gonda T.J., and Metcalf D. Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia. Nature 310 (1984) 249-251
5. Gewirtz A.M., and Calabretta B. A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science 242 (1988) 1303-1306
6. Westin E.H., Gallo R.C., Arya S.K., Eva A., Souza L.M., Baluda M.A., Aaronson S.A., and Wong-Staal F. Differential expression of the amv gene in human hematopoietic cells. Proc. Natl. Acad. Sci. USA 79 (1982) 2194-2198
7. Ness S.A. The Myb oncoprotein: regulating a regulator. Biochim. Biophys. Acta 1288 (1996) F123-F139
8. Bartley P.A., Lutwyche J.K., and Gonda T.J. Identification and validation of candidate Myb target genes. Blood Cells Mol. Dis. 27 (2001) 409-415
9. Hogg A., Schirm S., Nakagoshi H., Bartley P., Ishii S., Bishop J.M., and Gonda T.J. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2. Oncogene 15 (1997) 2885-2898
10. Gonda T.J., Macmillan E.M., Townsend P.V., and Hapel A.J. Differentiation state and responses to hematopoietic growth factors of murine myeloid cells transformed by myb. Blood 82 (1993) 2813-2822
11. Sano Y., and Ishii S. Increased affinity of c-Myb for CREB-binding protein (CBP) after CBP-induced acetylation. J. Biol. Chem. 276 (2001) 3674-3682
12. Coles L.S., Diamond P., Lambrusco L., Hunter J., Burrows J., Vadas M.A., and Goodall G.J. A novel mechanism of repression of the vascular endothelial growth factor promoter, by single strand DNA binding cold shock domain (Y-box) proteins in normoxic fibroblasts. Nucleic Acids Res. 30 (2002) 4845-4854
13. Nishina Y., Nakagoshi H., Imamoto F., Gonda T.J., and Ishii S. Trans-activation by the c-myb proto-oncogene. Nucleic Acids Res. 17 (1989) 107-117
14. Kanei-Ishii C., MacMillan E.M., Nomura T., Sarai A., Ramsay R.G., Aimoto S., Ishii S., and Gonda T.J. Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure. Proc. Natl. Acad. Sci. USA 89 (1992) 3088-3092
15. Kanei-Ishii C., Sarai A., Sawazaki T., Nakagoshi H., He D.N., Ogata K., Nishimura Y., and Ishii S. The tryptophan cluster: a hypothetical structure of the DNA-binding domain of the myb protooncogene product. J. Biol. Chem. 265 (1990) 19990-19995
16. Sakura H., Kanei-Ishii C., Nagase T., Nakagoshi H., Gonda T.J., and Ishii S. Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc. Natl. Acad. Sci. USA 86 (1989) 5758-5762
17. Nordeen S.K. Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6 (1988) 454-458
18. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Smith J.A., Seidman J.G., and Struhl K. Current Protocols in Molecular Biology (1994), John Wiley and Sons Inc., New York
19. Berger J., Hauber J., Hauber R., Geiger R., and Cullen B.R. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 66 (1988) 1-10
20. Bartley P.A., Keough R.A., Lutwyche J.K., and Gonda T.J. Regulation of the gene encoding glutathione S-transferase M1 (GSTM1) by the Myb oncoprotein. Oncogene 22 (2003) 7570-7575
21. Shima D.T., Kuroki M., Deutsch U., Ng Y.S., Adamis A.P., and D'Amore P.A. The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J. Biol. Chem. 271 (1996) 3877-3883
22. Milanini J., Vinals F., Pouyssegur J., and Pages G. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. J. Biol. Chem. 273 (1998) 18165-18172
23. Kanei-Ishii C., Yasukawa T., Morimoto R.I., and Ishii S. c-Myb-induced trans-activation mediated by heat shock elements without sequence-specific DNA binding of c-Myb. J. Biol. Chem. 269 (1994) 15768-15775
24. Kanei-Ishii C., Tanikawa J., Nakai A., Morimoto R.I., and Ishii S. Activation of heat shock transcription factor 3 by c-Myb in the absence of cellular stress. Science 277 (1997) 246-248
25. Foos G., Natour S., and Klempnauer K.H. TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins. Oncogene 8 (1993) 1775-1782
26. Plaza S., Turque N., Dozier C., Bailly M., and Saule S. C-Myb acts as transcriptional activator of the quail PAX6 (PAX-QNR) promoter through two different mechanisms. Oncogene 10 (1995) 329-340
27. Kenney S.C., Holley-Guthrie E., Quinlivan E.B., Gutsch D., Zhang Q., Bender T., Giot J.F., and Sergeant A. The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells. Mol. Cell. Biol. 12 (1992) 136-146
28. Aurigemma R.E., Blair D.G., and Ruscetti S.K. Transactivation of erythroid transcription factor GATA-1 by a myb-ets-containing retrovirus. J. Virol. 66 (1992) 3056-3061
29. Sun-Hoffman L., Aurigemma R.E., Sun B., and Ruscetti S.K. Transactivation of the GATA-1 promoter by a myb-ets-containing mouse retrovirus is mediated by CACCC elements. Oncogene 13 (1996) 1037-1042
30. Sala A., Saitta B., De Luca P., Cervellera M.N., Casella I., Lewis R.E., Watson R., and Peschle C. B-MYB transactivates its own promoter through SP1-binding sites. Oncogene 18 (1999) 1333-1339
31. Ibanez C.E., and Lipsick J.S. Trans activation of gene expression by v-myb. Mol. Cell. Biol. 10 (1990) 2285-2293
32. Black A.R., Black J.D., and Azizkhan-Clifford J. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell Physiol. 188 (2001) 143-160
33. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat. Rev. Cancer 2 (2002) 795-803
34. Dias S., Hattori K., Zhu Z., Heissig B., Choy M., Lane W., Wu Y., Chadburn A., Hyjek E., Gill M., Hicklin D.J., Witte L., Moore M.A., and Rafii S. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J. Clin. Invest. 106 (2000) 511-521
35. Bellamy W.T., Richter L., Sirjani D., Roxas C., Glinsmann-Gibson B., Frutiger Y., Grogan T.M., and List A.F. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. Blood 97 (2001) 1427-1434
36. Aguayo A., Estey E., Kantarjian H., Mansouri T., Gidel C., Keating M., Giles F., Estrov Z., Barlogie B., and Albitar M. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood 94 (1999) 3717-3721
37. Slamon D.J., Boone T.C., Murdock D.C., Keith D.E., Press M.F., Larson R.A., and Souza L.M. Studies of the human c-myb gene and its product in human acute leukemias. Science 233 (1986) 347-351
38. Padro T., Ruiz S., Bieker R., Burger H., Steins M., Kienast J., Buchner T., Berdel W.E., and Mesters R.M. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 95 (2000) 2637-2644
39. Padro T., Bieker R., Ruiz S., Steins M., Retzlaff S., Burger H., Buchner T., Kessler T., Herrera F., Kienast J., Muller-Tidow C., Serve H., Berdel W.E., and Mesters R.M. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia. Leukemia 16 (2002) 1302-1310
40. Hussong J.W., Rodgers G.M., and Shami P.J. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 95 (2000) 309-313
41. Gerber H.P., Malik A.K., Solar G.P., Sherman D., Liang X.H., Meng G., Hong K., Marsters J.C., and Ferrara N. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417 (2002) 954-958
42. Thompson M.A., and Ramsay R.G. Myb: an old oncoprotein with new roles. Bioessays 17 (1995) 341-350
43. Guerin M., Sheng Z.M., Andrieu N., and Riou G. Strong association between c-myb and oestrogen-receptor expression in human breast cancer. Oncogene 5 (1990) 131-135
44. Bachelder R.E., Crago A., Chung J., Wendt M.A., Shaw L.M., Robinson G., and Mercurio A.M. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res. 61 (2001) 5736-5740
45. Price D.J., Miralem T., Jiang S., Steinberg R., and Avraham H. Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells. Cell Growth Differ. 12 (2001) 129-135
46. Ramsay R.G., Barton A.L., and Gonda T.J. Targeting c-Myb expression in human disease. Expert Opin. Ther. Targets 7 (2003) 235-248
47. Zar J.H. Biostatistical Analysis. Second ed. (1984), Prentice-Hall, New Jersey